Skip to main content
. 2024 Aug 1;16(15):2746. doi: 10.3390/cancers16152746

Table 2.

Summary of advantages and disadvantages of different screening modalities for colon cancer screening.

Screening Method Technique Advantages Disadvantages
Colonoscopy Involves the insertion of a flexible tube with a camera (colonoscope) into the rectum to examine the entire colon for polyps or cancerous growths. -Direct visualization allows for the detection and removal of precancerous polyps during the procedure. -Requires bowel preparation, which may be uncomfortable.
-Invasive procedure with a small risk of complications, such as bleeding or perforation.
Flexible Sigmoidoscopy Involves the insertion of a thin, flexible tube with a camera (sigmoidoscope) into the rectum and lower part of the colon to examine for polyps or cancerous growths. -Less invasive than colonoscopy.
-Does not require full bowel preparation.
-Limited in scope compared to colonoscopy; only examines the lower part of the colon.
-Polyps or cancers in the upper colon may be missed.
-Positive findings require follow-up colonoscopy.
CT Colonography Uses CT scans to create detailed images of the colon and rectum, allowing for the detection of polyps or cancerous growths. -Noninvasive and does not require sedation.
-No risk of perforation.
-Provides detailed images of the entire colon.
-Requires bowel preparation similar to colonoscopy.
-Polyps found may require follow-up colonoscopy for removal.
-Radiation exposure from CT scans.
Capsule Endoscopy Capsule endoscopy involves swallowing a small camera that captures images of the colon as it passes through the digestive tract. -Noninvasive
-No need for sedation
-Provides comprehensive visualization of the entire GI tract
-Better detection of polyps and early cancers
-Requires bowel preparation
-Limited availability and accessibility
-Risk of capsule retention
-Not therapeutic; positive findings require follow-up colonoscopy
-Possible technical issues (e.g., battery life, transmission problems)
Fecal Immunochemical Test (FIT) A stool-based test that detects hidden blood in the stool, which can be a sign of colorectal cancer or polyps. -Noninvasive and simple to perform at home. No dietary or medication restrictions before the test.
-No need for bowel preparation.
-Can produce false-positive results due to bleeding from other sources (e.g., hemorrhoids).
-Sensitivity may vary, and polyps or early-stage cancer may not always be detected.
-A follow-up colonoscopy is required if the test is positive.
Stool DNA Test (mt-sDNA) A stool-based test that combines FIT with analysis of DNA markers associated with colorectal cancer. -Higher sensitivity for detecting advanced adenomas and colorectal cancer compared to FIT alone.
-Noninvasive and can be performed at home without dietary or medication restrictions.
-More expensive than FIT.
-False-positive results can occur, leading to unnecessary follow-up testing.
-Requires collection of multiple stool samples.
gFOBT gFOBT detects hidden blood in stool samples, suggesting bleeding from polyps or cancer using guaiac-based chemical tests. -Noninvasive
-Easy to perform at home
-No need for bowel preparation
-Low cost
-No sedation needed
-Lower sensitivity and specificity compared to other methods
-High false-positive rate
-Requires multiple samples
-Dietary restrictions prior to the test
-Not diagnostic; positive results need follow-up colonoscopy
-Can miss polyps and early cancers

ACG: American College of Gastroenterology; USMSTF: United State Multi-Society Task Force; ACS: American Cancer Society; USPSTF: United States Preventive Services Task Force; NCCN: National Comprehensive Cancer Network; ACP: American College of Physicians; gFOBT: guaiac fecal occult blood test; FIT: fecal immunohistochemical test; mt-sDNA: Multi-Target Stool DNA.